Literature DB >> 24770898

Carbon dioxide levels during polygraphy in children with sleep-disordered breathing.

Jade Pautrat1, Sonia Khirani, Michèle Boulé, Adriana Ramirez, Nicole Beydon, Brigitte Fauroux.   

Abstract

PURPOSE: The recent scoring rules of the American Academy of Sleep Medicine (AASM) define hypoventilation in children as a carbon dioxide (CO2) level of >50 mmHg for >25 % of total sleep time (partial pressure of CO2 (PCO2) > 50[>25 %]). As there is no validated level of nocturnal hypoventilation with regard to end-organ damage in children, we evaluated the prevalence of hypoventilation with the AASM definition but also with a lesser degree of elevated CO2 in children with sleep-disordered breathing (SDB).
METHODS: Transcutaneous CO2 (PtcCO2) was recorded during overnight polygraphy (PG). Hypoventilation was defined according to four definitions: the AASM score (PCO2 > 50[>25 %]), the peak value of PtcCO2 > 50 mmHg (PtcCO2 > 50[peak]), a percentage of PtcCO2 > 50 mmHg > 2 % of nighttime recording (PtcCO2 > 50[>2 %]) or a nocturnal PtcCO2 > 10 mmHg above waking baseline level (PtcCO2[>10 mmHg]). PtcCO2 indices were correlated to the apnoea-hypopnoea index (AHI) and oxygenation indices.
RESULTS: PGs from 221 children with suspicion of obstructive sleep apnoea (72 %), neuromuscular diseases (21 %), and lung diseases (7 %) were analysed. The prevalence of hypoventilation according to PCO2 > 50[>25 %], PtcCO2 > 50[peak], PtcCO2 > 50[>2 %] and PtcCO2[>10 mmHg] were 16, 27, 31 and 52 %, respectively, and did not differ between the three diagnostic groups. Significant but weak correlations were observed between hypoventilation and AHI and oxygenation indices.
CONCLUSIONS: Nocturnal hypoventilation occurs in a large number of children referred for SDB, independent of the underlying disease, when more stringent criteria than those of the AASM are used. The poor correlation between hypoventilation and AHI or oxygenation indices is in favour of CO2 being a supplemental index of SDB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770898     DOI: 10.1007/s11325-014-0980-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  18 in total

1.  Obstructive hypopneas in children and adolescents: normal values.

Authors:  Manisha B Witmans; Thomas G Keens; Sally L Davidson Ward; Carole L Marcus
Journal:  Am J Respir Crit Care Med       Date:  2003-12-15       Impact factor: 21.405

2.  Transcutaneous carbon dioxide monitoring and capnography during pediatric polysomnography.

Authors:  Valerie G Kirk; Eldridge D Batuyong; Shelly G Bohn
Journal:  Sleep       Date:  2006-12       Impact factor: 5.849

Review 3.  The AASM Scoring Manual four years later.

Authors:  Madeleine M Grigg-Damberger
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

4.  Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

5.  Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors.

Authors:  F J O'Donoghue; P G Catcheside; E E Ellis; R R Grunstein; R J Pierce; L S Rowland; E R Collins; S E Rochford; R D McEvoy
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

Review 6.  Pathophysiology of upper airway obstruction: a developmental perspective.

Authors:  Raanan Arens; Carole L Marcus
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

7.  Development of a WHO growth reference for school-aged children and adolescents.

Authors:  Mercedes de Onis; Adelheid W Onyango; Elaine Borghi; Amani Siyam; Chizuru Nishida; Jonathan Siekmann
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

8.  Transcutaneous and end-tidal carbon dioxide pressures should be measured during pediatric polysomnography.

Authors:  A Morielli; D Desjardins; R T Brouillette
Journal:  Am Rev Respir Dis       Date:  1993-12

Review 9.  Diagnosis and management of childhood obstructive sleep apnea syndrome.

Authors:  Carole L Marcus; Lee Jay Brooks; Kari A Draper; David Gozal; Ann Carol Halbower; Jacqueline Jones; Michael S Schechter; Sally Davidson Ward; Stephen Howard Sheldon; Richard N Shiffman; Christopher Lehmann; Karen Spruyt
Journal:  Pediatrics       Date:  2012-08-27       Impact factor: 7.124

10.  Normal polysomnographic values for children and adolescents.

Authors:  C L Marcus; K J Omlin; D J Basinki; S L Bailey; A B Rachal; W S Von Pechmann; T G Keens; S L Ward
Journal:  Am Rev Respir Dis       Date:  1992-11
View more
  4 in total

1.  Parent-child co-sleeping in children with co-morbid conditions and sleep-disordered breathing.

Authors:  Lynda Sidhoum; Alessandro Amaddeo; Jorge Olmo Arroyo; Livio De Sanctis; Sonia Khirani; Brigitte Fauroux
Journal:  Sleep Breath       Date:  2018-09-05       Impact factor: 2.816

2.  Management of respiratory complications and rehabilitation in individuals with muscular dystrophies: 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Milan, January 25-26, 2019).

Authors:  Fabrizio Rao; Giancarlo Garuti; Michele Vitacca; Paolo Banfi; Fabrizio Racca; Renato Cutrera; Martino Pavone; Marina Pedemonte; Matteo Schisano; Stefania Pedroni; Jacopo Casiraghi; Andrea Vianello; Valeria A Sansone
Journal:  Acta Myol       Date:  2021-03-31

3.  Assessment of Nocturnal Hypoventilation by Different Methods and Definitions in Children with Neuromuscular Disease: Oxycapnography and Blood Gas Analysis.

Authors:  Yetkin Ayhan; Elif Yuksel Karatoprak; Zeynep Reyhan Onay; Sinem Can Oksay; Saniye Girit
Journal:  Medeni Med J       Date:  2021-06-18

4.  Detection of early nocturnal hypoventilation in neuromuscular disorders.

Authors:  Federica Trucco; Marina Pedemonte; Chiara Fiorillo; Hui-Leng Tan; Annalisa Carlucci; Giacomo Brisca; Paola Tacchetti; Claudio Bruno; Carlo Minetti
Journal:  J Int Med Res       Date:  2017-12-06       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.